Cargando…

Direct Oral Anticoagulants versus Vitamin K Antagonists in Individuals Aged 80 Years and Older: An Overview in 2021

Two main types of oral anticoagulants are available in France: vitamin K antagonists (VKA) and, more recently, direct oral anticoagulants (DOAC). The benefit–risk profile appears to be favorable for DOAC, which is as effective as VKA but safer (fewer cases of severe and cerebral bleeding). In a stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azzoug, Chana, Nuémi, Gilles, Menu, Didier, De Maistre, Emmanuel, Boulin, Mathieu, Putot, Alain, Manckoundia, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859400/ https://www.ncbi.nlm.nih.gov/pubmed/36674204 http://dx.doi.org/10.3390/ijerph20021448

Ejemplares similares

Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients Aged 80 Years and Older
por: Manckoundia, Patrick, et al.
Publicado: (2021)

The Prescription of Vitamin K Antagonists in a Very Old Population: A Cross-Sectional Study of 8696 Ambulatory Subjects Aged Over 85 Years
por: Manckoundia, Patrick, et al.
Publicado: (2020)

Changes in Treatment of Very Elderly Patients Six Weeks after Discharge from Geriatrics Department
por: Dipanda, Mélanie, et al.
Publicado: (2020)

Impact of Influenza Vaccination on Mortality in the Oldest Old: A Propensity Score-Matched Cohort Study
por: Walzer, Pauline, et al.
Publicado: (2020)

Successful Management of Heparin-Induced Thrombocytopenia Using Argatroban in a Very Old Woman: A Case Report
por: Putot, A., et al.
Publicado: (2013)

Acute Care and Medication Management in Older Adults
por: Manckoundia, Patrick, et al.
Publicado: (2021)

Prognostic impact of systolic blood pressure in acute heart failure with preserved ejection fraction in older patients
por: Putot, Sophie, et al.
Publicado: (2021)

Assessment of the Health Status of the Oldest Olds Living on the Greek Island of Ikaria: A Population Based-Study in a Blue Zone
por: Legrand, Romain, et al.
Publicado: (2019)

Description of Lifestyle, Including Social Life, Diet and Physical Activity, of People ≥90 years Living in Ikaria, a Longevity Blue Zone
por: Legrand, Romain, et al.
Publicado: (2021)

Troponin Elevation in Older Patients with Acute Pneumonia: Frequency and Prognostic Value
por: Putot, Alain, et al.
Publicado: (2020)

Atypical Presentation of Bacteremic Urinary Tract Infection in Older Patients: Frequency and Prognostic Impact
por: Laborde, Caroline, et al.
Publicado: (2021)

Post-Infectious Myocardial Infarction: New Insights for Improved Screening
por: Putot, Alain, et al.
Publicado: (2019)

Not COVID-19, Don’t Overlook Pneumocystis in Patients on Gefitinib!
por: Barben, Jérémy, et al.
Publicado: (2021)

Acute Labyrinthitis Revealing COVID-19
por: Perret, Marie, et al.
Publicado: (2021)

Bedside chest ultrasound to distinguish heart failure from pneumonia‐related dyspnoea in older COVID‐19 patients
por: Hacquin, Arthur, et al.
Publicado: (2020)

Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021)

The Pivotal Role of Viruses in the Pathogeny of Chronic Lymphocytic Leukemia: Monoclonal (Type 1) IgG K Cryoglobulinemia and Chronic Lymphocytic Leukemia Diagnosis in the Course of a Human Metapneumovirus Infection
por: Barben, Jérémy, et al.
Publicado: (2021)

Geographic Variations in the Quality of Oral Anticoagulation With Vitamin K Antagonists in the Era of New Anticoagulants
por: Fauchier, Laurent, et al.
Publicado: (2013)

Gastrointestinal bleeding during anticoagulation with direct oral anticoagulants compared to vitamin K antagonists
por: Dongre, Kanchan, et al.
Publicado: (2022)

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
por: Peeters, Frederique E. C. M., et al.
Publicado: (2018)

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
por: Mujer, Mark Terence P., et al.
Publicado: (2020)

Type 2 Myocardial Infarction: A Geriatric Population-based Model of Pathogenesis
por: Putot, Alain, et al.
Publicado: (2020)

Mid-Term Mortality in Older Anemic Patients with Type 2 Myocardial Infarction: Does Blood Transfusion sImprove Prognosis?
por: Hacquin, Arthur, et al.
Publicado: (2022)

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
por: Dincq, Anne-Sophie, et al.
Publicado: (2014)

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis
por: Camilleri, Eleonora, et al.
Publicado: (2021)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
por: Malagù, Michele, et al.
Publicado: (2023)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
por: Kumano, Osamu, et al.
Publicado: (2021)

Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
por: Lee, Hyun-Jung, et al.
Publicado: (2023)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
por: Darche, Fabrice F., et al.
Publicado: (2023)

IMC et risque de mortalité à un an chez des patients très âgés hospitalisés pour COVID-19 : étude observationnelle
por: Putot, A., et al.
Publicado: (2023)

Iron in the General Population and Specificities in Older Adults: Metabolism, Causes and Consequences of Decrease or Overload, and Biological Assessment
por: Manckoundia, Patrick, et al.
Publicado: (2020)

High-Flow Nasal Cannula Oxygenation in Older Patients with SARS-CoV-2-Related Acute Respiratory Failure
por: Hacquin, Arthur, et al.
Publicado: (2021)

Comparative Risk of Bleeding of Anticoagulant Therapy with Vitamin K Antagonists (VKAs) and with Non-Vitamin K Antagonists in Patients Undergoing Dental Surgery
por: Manfredini, Mattia, et al.
Publicado: (2021)

Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants
por: Cullell, Natalia, et al.
Publicado: (2018)

Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants
por: Brinkmeier-Theofanopoulou, Maria, et al.
Publicado: (2018)

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact
por: Cariou, Eve, et al.
Publicado: (2021)

Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants
por: Faraoni, David, et al.
Publicado: (2015)

Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist
por: Carles, Misericòrdia, et al.
Publicado: (2015)

Impact of Non-vitamin K Antagonist Oral Anticoagulant Withdrawal on Stroke Outcomes
por: Park, Joong Hyun, et al.
Publicado: (2018)

Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
por: Gremmel, Thomas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mh42l93msrancoltofn5vohd6u